IL140890A0 - Adjuvant and vaccine compositions containing monophosphoryl lipid a - Google Patents

Adjuvant and vaccine compositions containing monophosphoryl lipid a

Info

Publication number
IL140890A0
IL140890A0 IL14089099A IL14089099A IL140890A0 IL 140890 A0 IL140890 A0 IL 140890A0 IL 14089099 A IL14089099 A IL 14089099A IL 14089099 A IL14089099 A IL 14089099A IL 140890 A0 IL140890 A0 IL 140890A0
Authority
IL
Israel
Prior art keywords
adjuvant
vaccine compositions
monophosphoryl lipid
compositions containing
containing monophosphoryl
Prior art date
Application number
IL14089099A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL140890A0 publication Critical patent/IL140890A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IL14089099A 1998-07-14 1999-07-13 Adjuvant and vaccine compositions containing monophosphoryl lipid a IL140890A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11539298A 1998-07-14 1998-07-14
PCT/US1999/015942 WO2000003744A2 (en) 1998-07-14 1999-07-13 Adjuvant and vaccine compositions containing monophosphoryl lipid a

Publications (1)

Publication Number Publication Date
IL140890A0 true IL140890A0 (en) 2002-02-10

Family

ID=22361090

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14089099A IL140890A0 (en) 1998-07-14 1999-07-13 Adjuvant and vaccine compositions containing monophosphoryl lipid a

Country Status (14)

Country Link
EP (1) EP1096954B1 (ko)
JP (1) JP2002520373A (ko)
KR (1) KR100586804B1 (ko)
CN (1) CN1247262C (ko)
AT (1) ATE278420T1 (ko)
AU (1) AU763770B2 (ko)
BR (1) BR9912067A (ko)
CA (1) CA2333578C (ko)
DE (1) DE69920915T2 (ko)
DK (1) DK1096954T3 (ko)
ES (1) ES2229745T3 (ko)
IL (1) IL140890A0 (ko)
PT (1) PT1096954E (ko)
WO (1) WO2000003744A2 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1141308T1 (sl) 1998-12-22 2007-08-31 Microscience Ltd Streptokokni proteini skupine B in njihova uporaba
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
PL206832B1 (pl) * 2000-05-19 2010-09-30 Corixa Corp Zastosowanie związków opartych na mono- i disacharydach
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
AP2745A (en) * 2005-08-02 2013-09-30 Novartis Vaccines & Diagnostic Reducing interference between oil-containing adjuvants and surfactant-containing antigens
EP2726097A4 (en) * 2011-07-01 2015-03-11 Univ California HERPES VIRUS VACCINE AND METHOD OF USE
US9241988B2 (en) * 2012-04-12 2016-01-26 Avanti Polar Lipids, Inc. Disaccharide synthetic lipid compounds and uses thereof
WO2015035010A1 (en) * 2013-09-05 2015-03-12 Immune Design Corp. Vaccine compositions for drug addiction
WO2023212702A2 (en) * 2022-04-28 2023-11-02 Kansas State University Research Foundation Corralling amphipathic peptide colloids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672496B3 (fr) * 1990-07-18 1993-05-28 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
EP0812593B8 (en) * 1993-03-23 2010-11-10 SmithKline Beecham Biologicals S.A. Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
GB9612137D0 (en) * 1996-06-10 1996-08-14 Quaker Oats Co Treatment of dried fruit
ATE298578T1 (de) * 1996-07-03 2005-07-15 Eisai Co Ltd Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung

Also Published As

Publication number Publication date
WO2000003744A3 (en) 2000-04-27
AU763770B2 (en) 2003-07-31
EP1096954B1 (en) 2004-10-06
AU5101899A (en) 2000-02-07
CN1307483A (zh) 2001-08-08
DE69920915D1 (de) 2004-11-11
DK1096954T3 (da) 2005-01-31
ES2229745T3 (es) 2005-04-16
CN1247262C (zh) 2006-03-29
CA2333578A1 (en) 2000-01-27
DE69920915T2 (de) 2006-02-16
KR20010071637A (ko) 2001-07-28
CA2333578C (en) 2010-11-16
JP2002520373A (ja) 2002-07-09
ATE278420T1 (de) 2004-10-15
WO2000003744A2 (en) 2000-01-27
BR9912067A (pt) 2001-04-10
PT1096954E (pt) 2004-12-31
KR100586804B1 (ko) 2006-06-07
EP1096954A2 (en) 2001-05-09

Similar Documents

Publication Publication Date Title
GB9725084D0 (en) Vaccine compositions
WO2003039330A3 (en) Devices and methods to correct spinal deformities
NZ508110A (en) Attenuated mutants of salmonella which constitutively express the Vi antigen
IL140710A0 (en) Pulmonary delivery of active agents
HUP0101323A1 (hu) Vakcinakészítmények
NZ513202A (en) Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde
CA2177667A1 (en) Mammalian vaccine compositions comprising squalene or squalane, lecithin and a polyoxyethylene sorbitan ester as an adjuvant
IL140890A0 (en) Adjuvant and vaccine compositions containing monophosphoryl lipid a
ATE210995T1 (de) Interleukin-11 präparat
WO2003059916A3 (en) Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids
DE69634024D1 (de) Adjuvans für vitale Impfstoffe
WO2000025815A8 (en) Novel immunoadjuvants
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
EP1891968A3 (en) Rotavirus vaccine formulations
WO1999027892A3 (de) Lagerstabile kationisch polymerisierende zubereitungen mit verbessertem härtungsverhalten
WO2000033887A3 (en) Methods and formulations for reducing circulating antibodies
AU2501795A (en) Branched polysaccharide, microorganism producing it and compositions containing them
AP9901666A0 (en) Leishmania vaccine.
AU6849198A (en) Neurotrypsin
BG105372A (en) Immunogenic liposome compositions
CA2442698A1 (en) Thermolabile liposome with controlled release temperature
WO1999016466A3 (en) Vaccine compositions and methods of enhancing vaccine efficacy
MXPA05009447A (es) Vacunas bovinas con adyuvante.
ZA997265B (en) Leptospira vaccine antigens for the prevention of leptospirosis.
EP1027895A3 (en) Erysipelothrix rhusiopathiae antigens and vaccine compositions

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees